Department of Clinical Oncology
Chinese University of Hong Kong
Research Interest :
Hepatitis B virus reactivation in chemotherapy, breast and gynaecological malignancies, and hepatocellular carcinoma
Selected Publications on Women's Health :
ˇ@
1.
W Yeo , WH Kwan, PML Teo, S Nip, E Wong, LY Hin, PJ Johnson. Psychosocial impact of breast cancer surgeries in Chinese patients and their spouses. Psycho-Oncology 200 4 , 13:132-139.
2.
W Yeo , WM Ho, P Hui, PKS Chan, KC Lam, JJ Lee, PJ Johnson. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patient. Breast Cancer Research and Treatment 2004 ; 88: 209-215 .
3.
Chua MS, Mok TS, Kwan WH, Yeo W , Zee B. Knowledge, perceptions, and attitudes of Hong Kong Chinese women on screening mammography and early breast cancer management. Breast J. 2005 Jan-Feb;11(1):52-6.
4.
W. Yeo , W. M. Ho, P. Hui, K.C. Lam, B. Zee, W.H. Kwan, P.K.S. Chan, J.J. Lee, P.J. Johnson. Lamivudine can reduce hepatitis B reactivation in HBsAg seropositive breast cancer patients during chemotherapy. The 9 th Annual Symposium of the Hong Kong Cancer Institute. ˇ§Anti-Cancer Drug Development- From Bench to Bedside to Marketˇ¨, 19-20 March 2004 , abstract book, p39, #20.
5.
B Zee, W Yeo , MP Lai, C Koh, HM Chu. LM Lee . Chemotherapy-induced nausea affects patients' quality of life (QOL) more than chemotherapy-induced vomiting. The 9 th Annual Symposium of the Hong Kong Cancer Institute. ˇ§Anti-Cancer Drug Development- From Bench to Bedside to Marketˇ¨, 19-20 March 2004 , abstract book, p 40, #22.
6.
W. Yeo , W. M. Ho, P. Hui, K. C. Lam, B. Zee, W. H. Kwan, P. K. S. Chan, J. J. Lee, P. J. Johnson. Lamivudine for the prevention of hepatitis B reactivation in HBsAg cancer patients undergoing cytotoxic chemotherapy- A prospective study. 4th European Breast Cancer Conference, European Journal of Cancer 2004; 2(3): 142. 16-20 March 2004.
7.
RR Deuson, B Zee, T Mok, W Yeo , F Mo, A Lee. Impact of nausea and vomiting on quality pf life in patients receiving moderately to highly emetogenic chemotherapy in Hong Kong. ISOQOL 11th Annual Scientific Conference October 16-19, 2004, Hong Kong.
8.
W Yeo , W-L Wong, N Wong, B Law, GM Tse, S Zhong. High frequency of promoter hypermethylation of RASSF1A in tumour and peritumoral tissue of breast cancer. Pathology 2005, 37(2): 125-130.
9.
T.S.K. Mok, W. Yeo , P. Hui, W.M. Ho, K.C. Lam, Z.R. Pan, W.C. Au, M. Xu, T.C. Chan, K. Chak, P. Johnson, B Zee. A Double-blind Placebo-control Randomized Study of the Efficacy of Chinese Herbal Medicine (CHM) in Reduction of Cytotoxic Chemotherapy-induced toxicity. Proceedings of American Society of Clinical Oncology 2005; 23 (16S pt 1): 768s.
10.
A Chang, J Beith, W Yeo , M Boyer, J Wong, S E Lim, A Chan. Phase I/II Study of Weekly Paclitaxel (P), UFT and Leucovorin in Patients with Metastatic Breast Cancer (MBC). A Cancer Therapeutic Research Group (CTRG) study. Proceedings of American Society of Clinical Oncology 2005; 23 (16S pt 1): 59s.
